Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5686928 | The Journal of Urology | 2017 | 24 Pages |
Abstract
Rebiopsy rates vary in Michigan practices with relatively low use in men with high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation or atypical small acinar proliferation alone. Quality improvement strategies should target patients with atypical small acinar proliferation and high grade prostatic intraepithelial neoplasia as they have the highest likelihood of cancer detection.
Keywords
NCCN®PSADREBlue Cross Blue Shield of MichiganBCBSMHGPINprostatic intraepithelial neoplasiaPCAProstate specific antigenMRIBiopsyquality improvementAtypical small acinar proliferationDiagnosisMagnetic resonance imagingProstate cancerNational Comprehensive Cancer Network®digital rectal examinationMUSICProstatic neoplasmsHigh grade prostatic intraepithelial neoplasiaASAPMichigan Urological Surgery Improvement Collaborative
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Frank N. Burks, Jonathan C. Hu, Dinesh Telang, Alice Liu, Scott Hawken, Zack Montgomery, Susan Linsell, James E. Montie, David C. Miller, Khurshid R. Ghani,